Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 741-760 of 3,347 trials

Cerebral Palsy Early Mobility Training

NCT02340026

The purpose of this study is to determine the optimal treatment duration of a novel early mobility training program (dynamic supported mobility, DSM) between 6 to 24 weeks of treatment; and to evaluate the clinical futility of this intervention compared to current rehabilitation practice.

Cerebral Palsy

Children's Hospital of Philadelphia42 participantsStarted Jan 2015

Philadelphia, Pennsylvania, United States

Active Not RecruitingPhase 2< 1 mile

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

NCT06390865

This phase II MATCH treatment trial tests how well MLN0128 (TAK-228) works in treating patients with cancer that has certain genetic changes called TSC1 or TSC2 mutations. MLN0128 (TAK-228) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more

National Cancer Institute (NCI)49 participantsStarted Mar 2017

Philadelphia, Pennsylvania, United States

Cerebral Palsy Early Mobility Training

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Rheumatoid Arthritis Trials in Other Cities

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

Studies of Brain and Body Interaction

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

OCS Heart Perfusion Post-Approval Registry

ZILRETTA in Subjects With Shoulder Osteoarthritis

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

Other Conditions in Philadelphia